Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Drug Discovery 2025, ELRIG – 04.07.2025
DDL 2025
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
HCMed

Things Pharmaceutical Supply Chain and Operations Directors Should Know, But Do Not

In considering supply chain operations in pharmaceuticals businesses, the naïve amongst us might assume that the answers to the basic questions are clear. How much inventory is enough?  What does it cost to make a tablet? Which plants are the most efficient producers? How much capacity do we have? How should we plan and organise how demand hits operations? What doesit cost to serve the customer? Dr John Harhen at Orbsen Consulting discusses that there is a fundamental lack of clarity to these most basic of questions.
 

https://international-pharma.com/wp-content/uploads/2012/12/1-Things-Pharmaceutical-Supply-Chain-and-Operations-Directors-Should-Know-But-Do-Not.pdf
YPSOMED website ad
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025